Vicks Sinex SEVERE VapoCOOL ULTRA FINE MIST .0005095 g/mL
Oxymetazoline Hydrochloride · SPRAY · Procter & Gamble Manufacturing GmbH
Vicks Sinex Severe Vapocool Ultra Fine Mist is a nasal spray containing oxymetazoline that helps relieve severe nasal congestion from colds, allergies, or sinus problems. This over-the-counter decongestant works by narrowing blood vessels in the nasal passages to reduce swelling and improve breathing.
Key Facts
- Brand Name
- Vicks Sinex SEVERE VapoCOOL ULTRA FINE MIST
- Generic Name
- Oxymetazoline Hydrochloride
- NDC Code (Product)
64336-173- Manufacturer
- Procter & Gamble Manufacturing GmbH
- Strength
- .0005095 g/mL
- Dosage Form
- SPRAY
- Route
- NASAL
- Marketing Status
- Application #
- M012
- Marketing Start
- 05/01/2020
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
Full Prescribing Information
Indications & Usage
Uses temporarily relieves nasal congestion due to a cold, hay fever, or other upper respiratory allergies sinus congestion and pressure
Dosage & Administration
Directions Remove protective cap. Before using for the first time, prime the pump by firmly depressing its rim several times. Hold container with thumb at base and nozzle between first and second fingers. Without tilting your head, inset nozzle into nostril. Fully depress rim with a firm, even stroke and inhale deeply. adults & children 6 yrs. & older (with adult supervision) 2 or 3 sprays in each nostril, not more often than every 10 to 12 hours. Do not exceed 2 doses in 24 hours. children 2 to under 6 yrs. ask a doctor children under 2 yrs. do not use
Warnings
Warnings Ask a doctor before use if you have heart disease high blood pressure thyroid disease diabetes trouble urinating due to enlarged prostate gland When using this product do not exceed recommended dosage do not use this product for more than 3 days. Use only as directed. Frequent or prolonged use may cause nasal congestion to recur or worsen temporary discomfort such as burning, stinging, sneezing, or increased nasal discharge may occur use of this container by more than one person may spread infection Stop use and ask a doctor if symptoms persist. If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away
Frequently Asked Questions
What is Vicks Sinex SEVERE VapoCOOL ULTRA FINE MIST used for?
Vicks Sinex Severe Vapocool Ultra Fine Mist is a nasal spray containing oxymetazoline that helps relieve severe nasal congestion from colds, allergies, or sinus problems. This over-the-counter decongestant works by narrowing blood vessels in the nasal passages to reduce swelling and improve breathing.
Is Vicks Sinex SEVERE VapoCOOL ULTRA FINE MIST a controlled substance?
Vicks Sinex SEVERE VapoCOOL ULTRA FINE MIST is not classified as a controlled substance by the DEA.
What is the generic name for Vicks Sinex SEVERE VapoCOOL ULTRA FINE MIST?
The generic name for Vicks Sinex SEVERE VapoCOOL ULTRA FINE MIST is Oxymetazoline Hydrochloride. There are 12 other brand versions of Oxymetazoline Hydrochloride.
What is the NDC code for Vicks Sinex SEVERE VapoCOOL ULTRA FINE MIST .0005095 g/mL?
The NDC (National Drug Code) for Vicks Sinex SEVERE VapoCOOL ULTRA FINE MIST .0005095 g/mL is 64336-173, listed by Procter & Gamble Manufacturing GmbH.
Other Oxymetazoline Brands
See all →- NO MORE NOSEBLEED.05 g/100mL73169-001
- Quality Choice Nasal Mist Severe Congestion.05 g/100mL83324-274
- Afrin Allergy Sinus Nasal.5 g/100mL11523-0073
- SinuFrin NeilMed7.5 mg/15mL13709-231
- Good Sense Nasal.5 mg/mL0113-0304
- Nasal.05 g/100mL30142-304
- SUDAFED OM Sinus Severe No Drip Nasal Mist with Cooling Menthol50 mg/100mL50580-368
- SUDAFED OM Sinus Severe Original50 mg/100mL50580-787
- Discount Drug Mart Severe Congestion Nasal.05 g/100mL53943-718
- Quality Choice.05 g/100mL63868-699
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)